FDA Approved: CYTARABINE — Original Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves the original application for CYTARABINE (cytarabine) from Meitheal Pharmaceuticals Inc., making a generic cytarabine product available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)

Snippet

ORIG AP for CYTARABINE (CYTARABINE)